Martingale Asset Management L P Ab Cellera Biologics Inc. Transaction History

Martingale Asset Management L P

  • $4.27 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$5.66 - $7.59 $127,372 - $170,805
-22,504 Reduced 12.36%
159,603 $1.03 Million
Q1 2023

May 12, 2023
BUY
$7.31 - $11.18 $440,354 - $673,483
60,240 Added 49.43%
182,107 $1.37 Million
Q4 2022

Feb 13, 2023
BUY
$9.48 - $14.52 $684,607 - $1.05 Million
72,216 Added 145.45%
121,867 $1.23 Million
Q3 2022

Nov 14, 2022
BUY
$9.2 - $13.68 $209,759 - $311,904
22,800 Added 84.91%
49,651 $492,000
Q2 2022

Aug 11, 2022
BUY
$5.72 - $10.65 $153,587 - $285,963
26,851 New
26,851 $285,000

Others Institutions Holding ABCL

# of Institutions
153
Shares Held
109M
Call Options Held
153K
Put Options Held
194K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $787M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email